Condition: Obesity · Sponsor: Novo Nordisk A/S
This study will look at how well CagriSema helps people living with obesity to lose weight and maintain the weight loss long-term. The study has 2 parts: The first part is called 'the main study' and the second part is called 'the extension study'. In the main study participants will either get CagriSema (a study medicine) or placebo (a dummy medicine that looks like CagriSema but has no active ingredient). Which treatment participants get is decided by chance. Participants are two times more likely to get CagriSema than placebo. If participants get CagriSema in the main study, participants will continue on CagriSema in the extension study. Which dose of CagriSema participants will continue on is decided by chance. If participants get placebo in the main study, participants will get CagriSema in the extension study. Participants will take one injection of study medicine once a week. The study will last for about 3 years and 3 months.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| FDRC | Costa Mesa, California, United States | — |
| Linda Vista Health Care Ctr | San Diego, California, United States | — |
| Diablo Clinical Research, Inc. | Walnut Creek, California, United States | — |
| Northeast Research Institute | Fleming Island, Florida, United States | — |
| Jacksonville Ctr For Clin Res | Jacksonville, Florida, United States | — |
| South Broward Research LLC | Miramar, Florida, United States | — |
| Florida Inst For Clin Res LLC | Orlando, Florida, United States | — |
| Oviedo Medical Research, LLC | Oviedo, Florida, United States | — |
| Center for Diab,Obes & Metab | Pembroke Pines, Florida, United States | — |
| Hope Clin Res & Wellness | Conyers, Georgia, United States | — |
| Endocrine Research Solutions | Roswell, Georgia, United States | — |
| Great Lakes Clinical Trials | Chicago, Illinois, United States | — |
+ 34 more locations — full list on the registry record.
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.